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Immunoconlpetent cells capable of recognizing antigens  most likely possess 
antigen-binding  receptors  on  their  membranes  and  hence  are  called  antigen- 
binding  cells  (ABC) 1 (1-5).  Ada and  Byrt  (6)  provided  a  direct  approach  to 
the study of ABC by showing that  exposure  of lymphoid cells  to radioactive 
flagellin  specifically  abolished  the  immune  response  to  that  antigen.  Their 
technique  is  termed  antigen-induced  "suicide"  because  the  flagellin-binding 
cells  are  "killed"  by  the  highly  radioactive  antigen  which  adheres  to  them. 
We now report that lymphoid cells recognizing dinitrophenyl  (DNP),  referred 
to as DNP-binding cells,  can be inactivated  specifically by highly radioactive 
DNP-protein  conjugates in which the radioactivity is not part of the hapten, 
but is solely confined to the carrier moiety. Moreover, the results show that the 
recognition  of DNP  by lymphoid cells is  independent  of the  carrier  to which 
DNP is bound. 
Materials and Methods 
Animals.--6-7-wk old male (C57BL/6 X DBA)FI (hereafter referred to as BDF1) were ob- 
taified from Jackson Laboratory, Bar Harbor, Maine. 
Haptens.--2,4-Dinitrophenyl sulfonic acid,  twice recrystallized,  (Eastman  Kodak  Co., 
Rochester, N.Y.) and picryl sulfonic acid (2,4,6-trinitrobenzene  sulfonic acid), twice recrystal- 
lized, (Nutritional  Biochemicals Corporation, Cleveland, Ohio) were used. 
Synthetic A ntigens.--~-DNP-lysine (~-DNP-Lys) was a gift from Dr. Frank Richard. 
Protein Carriers.--Keyhole limpet  hemocyanin  (KLH)  (Pacific Biomarine  Supply  Co., 
Venice, Calif.) ; human gamma globulin (HGG) (Pentex  Biochemical, Kankakee, Ill.) ; bovine 
serum albumin (BSA) (Armour Pharmaceutical Co., Chicago, Ill.); and isogenic mouse gamma 
globulin (MGG) were prepared as described elsewhere (7). 
* These studies were supported by U.S. Public Health Service grant Nos. AI 09825-02 from 
the Immunology Branch,  the National  Institute of Allergy and Infectious Diseases, and AM 
07937 from the National Institute of Arthritis and Metabolic Disease. 
Present address: Clinical Immunology, Department of Medicine, Rambam Hospital, 
Aba Khoushi School of Medicine, Haifa, Israel. 
1Abbreviations used in  this paper: ABC,  antigen-binding  cells; BDF1,  (C57BL/6  X 
DBA)F1 ; BSA, bovine serum albumin;  CFA,  complete Freund's adjuvant; DNP,  dinitro- 
phenyl;  ~-DNP-Lys, ~-DNP-lysine; HGG, human gamma globulin; KLH, keyhole  limpet 
hemocyanin; MGG, isogenic mouse gamma globulin; PFC, plaque-forming cells; SRBC, sheep 
red blood cells; TNP, trinitrophenyl. 
THE  JOURNAL OF  EXPERIMENTAL MEDICINE • VOLUME 136,  1972  305 306  DELETION  OF  HAPTEN-BINDING  CELLS  BY  125I 
Hapten-Protein  Carrier Conjugates.--The  following conjugates were used  (after prepara- 
tion as  previously  described  [7]):  DNP48-KLH,  DNPe2-KLH, DNPs6-KLH,  DNP~I-BSA, 
DNP3~-HGG,  DNP10-MGG, and TNPn0-KLH. 
Iodination  of Conjugated or Unconjugated Protein Carriers.--Iodination  with carrier-free 
125I (New England Nuclear Corp., Boston, Mass.; catalogue No. NEZ-033) was done by the 
chloramine-T method (8), as modified by Unanue (9). The specific activity and degree of sub- 
stitution of each preparation will be detailed in the results. 
X-Irradiation.--Recipient  mice were  irradiated with 960  R  using a  Westinghouse deep 
therapy unit (Westinghouse Electric Corp., Pittsburgh, Pa.)  (250 kv, 15 mA, target distance 
50 cm). The mice were placed in a Lucite container which was divided into 12 cells. This was 
rotated on a turntable to insure a uniform exposure to the X-rays. 
Spleen Call Suspensions.--Spleens  were excised, pooled, and minced with scissors.  The frag- 
ments were gently pressed through a tantalum gauze and suspended (50 X  106 cells/ml) in a 
10% fetal calf serum in minimal essential Eagle's medium (Microbiological Associates, Inc., 
Bethesda, Md.)  supplemented with glutamine,  penicillin, and  streptomycin in appropriate 
concentration, after being washed twice. 
Experimental Design.--Spleen  cells of unprimed mice were incubated in vitro on a rotating 
table with unlabeled or  125I-labeled  antigen at 0°C for 2 hr (in two separate experiments the 
exposure times were 30 rain and 23 hr, respectively). The concentration of the antigen was 1 
#g of protein/50 X  106 spleen ceils per ml of medium. The cells were then washed twice with 
the same medium and collected by centrifugation at low speed at 4°C,  and  their viability 
checked  by  the  trypan blue  exclusion  test  (a  viability  of  95%  was  the  usual  result). 
The  radioactivity of the cells recovered in the centrifuged pellet was  0.2~).5% of  the orig- 
inal amount. 50 )<  106 of the treated cells (resuspended in 0.2  0.3 ml of medium) were then 
injected intravenously into lethally irradiated syngeneic recipient mice. 
Immunization.--1  hr after the adoptive transfer, recipients were immunized with 1 nag of 
DNP-KLH  (DNP62-KLH  or  DNPs6-KLH)  given  intraperitoneally  (i.p.)  in  complete 
Freund's adjuvant (CFA), or, in some instances, with 1 mg of TNP-KLH  or 0.1  ml  of 20% 
sheep red blood cells (SRBC, Colorado Serum Co., Denver, Colo.) in saline. 
Hemolytic Plaque Assay.--8  days  after immunization, the mice were sacrificed and their 
splenic direct plaque-forming cells (PFC) were enumerated by Rittenberg's modification (10) 
of Jerne's hemolytic plaque assay (1 l) in which trinitrophenyl (TNP)-coated SRBC are us.d 
to detect the anti-DNP response. TNP is used because conjugation of DNP to SRBC is, for 
technical reasons, unreliable. The antibody detected by this method is actually anti-DNP that 
cross-reacts with TNP; for the sake of brevity, the PFC  detected by this method will be re- 
ferred to as anti-DNP PFC. In the case of mice immunized with TNP-KLH,  the same target 
cells were used, whereas, SRBC were used as target cells when the anti-SRBC response was 
tested.  In certain instances, indirect PFC  were  revealed by a  rabbit anti-mouse IgG anti- 
serum (12). 
Statistical Analysis.--Statistical  analysis was done according to Student's t test. For PFC, 
the geometric mean for each group was calculated. 
RESULTS 
Kinetics  of Inactivation  of the  DNP-Binding  Cells.--In  preliminary  experi- 
ments,  it was found  that incubation of spleen cells with ~2~I-labeled antigen for 
30 rain resulted in a  significant diminution of their immune  response to DNP. 
Increasing  the  incubation  for  2  hr  further  decreased  the  immune  response, 
when compared with controls incubated with unlabeled DNP-KLH.  However, 
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quent  experiments  were  carried  out  using  an  in  vitro  exposure  time  to  the 
radioactive antigen of 2 hr. 
Specific Deletion of the Anti-DN_P Response.--Spleen  cells of unprimed male 
BDF1 mice were incubated in vitro on a  rotating table with unlabeled or ~25I- 
labeled DNP48-KLH  (5  #Ci/106  spleen  cells; moles  of iodide/moles of KLH 
ranged  from  90  to  100;  specific activity ranged  from  232  to  250  #Ci/#g)  at 
0°C  for  2  hr.  Cells incubated  with  DNP-KLH-'25I  were  unable  to mount  a 
response in the irradiated host to DNP.  The suppression involved both direct 
20,000-  1  16,000- 
a_  12,000- 
8 000" 
~  4ooo-_ 
1/2  2  23 
HOURS 
FIG. 1.  Kinetics of inactivation of the D.NP-binding cells. Mouse spleen cells were incu- 
bated in vitro with DNP-KLH-12~I  or DNP-KLH for ~  hr, 2 hr, or 23 hr and then trans- 
ferred to lethally irradiated isogeneic recipient mice, which were  challenged with  1 mg of 
DNP62-KLH  i.p. in CFA. PFC were assayed 8 days later. Hatched column represents the 
geometrical mean of the number of direct PFC  (4- sE) in 10 control mice repopulated with 
spleen cells incubated with unlabeled DNP48-KLH (0.02 #g/106 spleen cells at 0°C) for 23 hr. 
White columns represent the geometrical mean of direct PFC (-4- sE) in experimental animals 
(6-10 per group) repopulated with spleen cells incubated with DNP48-KLH-125I for different 
time intervals (5/zCi/10 ~ spleen cells; specific activity 232 #Ci//zg antigen; 0.02/zg/106  cells) 
at 0°C. The results with cells incubated for 30 rain and for 2 hr were significantly different 
(0.02 <  P  <  0.05 and 0.001 < P< 0.01, respectively)  from the control group; there was no 
statistical difference between  the results of 23 hr incubation and 2 hr incuation when com- 
pared among themselves. Vertical bar represents one sE. 
and indirect PFC to DNP, indicating that both 19S and 7S antibody formation 
depend on  the presence of DNP-binding cells. Whether one or two subpopula- 
tions of hapten-binding cells mediate both immune responses is unknown.  The 
suppression was antigen specific because recipients of cells treated with DNP- 
KLH-I~sI  were  able  to  respond  normally  to  an  unrelated  antigen,  namely 
SRBC  (Table I). 
Are the "Natural" or Background A nti-DN P PFC the ttapten-Binding Cells?- 
To test this, two experiments were carried out. In one, direct PFC were assayed 
24 hr  after in vitro incubation of unprimed BDF1 spleen cell suspensions, for 
2 or 24 hr, with DNP-KLHJ25I. In the other, the influence of incubating spleen 
cells with the radioactive conjugate was tested in an adoptive transfer system. 
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PFC  (Table  II).  Thus,  the  natural  anti-DNP  PFC  are  not  affected  by  the 
highly  radioactive  antigen,  and,  therefore,  they  are  not  the  DNP-binding 
cells  required  for  the  immune  response  to  DNP-KLH.  The  observation,  in 
TABLE I 
Specific Deletion of the Anti-DNP Response 
No.  In vitro pretreatment  PFC/spleen  (4- sE)~: 
of  Immunization* 
mice  of cells  Direct (19S)  Indirect (7S) 
6  DNP4s-KLH  DNP~2-KLH  22,751  (4977)  17,709  (8351) 
6  DNP4s-KLH-125I  "  3624  (1539)§  1526  (1234)§ 
8  DNP4 s-KLH  SRBC  4603  (1109)  -- 
9  DNP48-KLH  -125I  "  3589  (1161) I[  -- 
* Immunized with 1.0 mg of DNP62-KLH in CFA i.p.  or 0.1  ml of 20%  SRBC in saline 
i.p. 
2~ Geometrical mean of anti-DNP PFC or anti-SRBC PFC/spleen (4- sE). 
§ DNP-KLH-125I-treated  group  differed significantly from the control group  (0.001  < 
P  <  0.01 for direct anti-DNP PFC and 0.05  <  P  <  0.1 for indirect anti-DNP PFC). 
11 Direct anti-SRBC PFC did not differ significantly in groups treated with DNP4s-KLH- 
125I or DNP4s-KLH. The low number of anti-SRBC PFC is explained by the fact that the 
assay was done 8 days after immunization, i.e., 3 days ~fter the peak of the response to SRBC. 
TABLE  II 
Failure to Suppress Background Anti-DNP PFC by 125I-Labeled DNP KLH 
Pretreatment of 
spleen cells 
PFC/10s  spleen cells 
at 24 hr 
PFC/10 6 spleen cells  (=l= SE)§ 
at 8 days after adoptive transfer 
SRBC  DNP  Corrected 
DNP  SRBC PFC  DNP PFC  Corrected 
PFC  PFC  PFC:~  DNP PFC:~ 
DNP-KLH  0.3  2.6  2.3  12.4  (2.8)  39.4  (18.4)  27.0  (18.4) 
DNP-KLH-12sI  * (2hr)  0.3  2.3  2.0  12.4  (2.8)  31.5  (2.9)  19.1  (2.9)H 
DNP-KLH-X25I  * (24 hr)  0.3  3.4  3.1  --  --  -- 
*  DNP~s-KLH-125I  specific  activity 234  /zCi/#g  antigen;  5  /zCi/106 spleen  cells;  0.02 
#g/106 spleen cells. 
:~ Background anti-DNP PFC corrected by subtraction  of background anti-SRBC  PFC. 
§ Lethally irradiated  mice  (four  to  eight  per  group)  were repopulated  with  50  X  106 
spleen cells from unprimed donors. These spleen cells had been incubated in vitro for 2 hr 
with  DNP4s-KLH  or  DNP48-KLH-125I.  8  days later  the  background  PFC  to  DNP  and 
SRBC were assayed. Data are the geometrical mean (=1= SE) of each group. 
[[ There was no significant difference  between anti-DNP PFC in groups treated with un- 
labeled or with 125I-labeled DNP KLH. 
nonimmunized  animals,  that  most  of  the  lymphoid  cells  which  bind  SRBC 
(the  rosette-forming  cells)  are  not  the  background  PFC  to  SRBC  supports 
this conclusion  (13). 
ttapten  Specificity  of Inactivation.--This  was  determined  in  the  next  set  of 
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late  two groups of lethally  irradiated  recipient  mice,  one  of which  was  chal- 
lenged with I)NP-KLH and the other with TNP-KLH  (Table III). The PFC 
producing  anti-DNP  cross reactive  with  TNP  (elicited  by DNP-KLH)  were 
suppressed  (group 3), but the PFC elicited by immunization with TNP-KLH 
were  unaffected  (group  4).  Second,  it  should  be  noted  that  hapten-binding 
cells can be deleted in a  noncross-reacting system; i.e.,  incubation with TNP- 
KLH-I~SI abolished  the immune response  to TNP-KLH  as tested  with  TNP- 
SRBC  target  cells  (group  7).  Third,  incubation  of  spleen  cells  with  TNP- 
TABLE III 
Hapten Specificity of Suppression by  Treatment with DNP-KLH-t25I or  TNP-KLH-125I 
In vitro pretreatment of cells 
Group  ~Ci/tLg  uCi/lO~  Immunization*  PFC/spleen (-4- sE):~ 
Antigen  antigen  cells 
1  DNP48-KLH  --  --  DNP62-KLH  19,087  (3133) 
2  TNPllo-KLH  --  --  TNPno-KLH  33,437  (9182) 
3  DNP48-KLH-125I  100  5  DNP62-KLH  2254  (859)§ 
4  193  5  TNPll0-KLH  29,047  (7877) [[ 
5  293  5  DNP62-KLH  1004 (509)§ 
6  194  9  TNPn0-KLH  33,225  (8085) 11 
7  TNP110-KLH-1~sI  293  25  TNPll0-KLH  5496  (1220)¶ 
* 1 mg of antigen DNP-KLH or TNP-KLH in CFA i.p. 
Data represent the geometrical mean of anti-DNP PFC or anti-TNP PFC of each group 
(five to eight per group) (-4- sE). 
§ Experimental  groups when compared with control mice immunized with DNP62-KLH 
differed significantly (P <  0.001). 
II Not significantly different when compared with control mice immunized with TNPn0- 
KLH. 
¶ Experimental  group when compared with control mice immunized with TNPn0-KLH 
differed significantly (P <  0.001). 
KLH-125I resulted in suppression of the DNP response as tested by TNP-SRBC 
(group 5). Judging by the relative amounts of radioactivity required to abolish 
responses  to DNP  or TNP,  some DNP-binding  cells  seem  to be more radio- 
sensitive than those responding to TNP only (group 6). 
Lack of Carrier Specificity in the Deletion of DNP-Binding Cells by Different 
D:yp-I~5I  Conjugates.--We  next  determined  whether  inactivation  of  DNP- 
binding  cells  by the  radioactive  conjugate was  carrier  specific; i.e.  if  the  im- 
mune  response  to  the  hapten  is  suppressed  only when  the  conjugate used  to 
inactivate  the  spleen  cells  in  vitro,  and  the  one  employed  to  challenge  the 
recipient  animals in vivo, are the same. Three different 125I-labeled  conjugates 
of DNP  (aside  from DNP-KLH-125I) were used  to treat  spleen  cells  in vitro. 
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KLH. The experimental design was  similar  to the preceding,  except for the 
differences in conjugates. In all instances, the direct anti-DNP PFC were sup- 
pressed  (Fig.  2).  By  contrast,  no  decrease  (the  increased  numbers  of  PFC 
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FIG. 2.  Absence of carrier specificity by different DNP-carrler protein  J 2  51 conjugates. The 
hatched column represents the geometrical mean of the number of direct PFC  (4-  SE) in a 
group of 10 control mice repopulated with spleen cells  treated with nonradioactive DNP4s- 
KLH.  The different white columns represent the geometrical mean of the number of direct 
anti-DNP PFC (4- SE) of groups of mice (6-12 per group) repopulated with spleen cells treated 
with different 12~I-labeled  antigens, i.e.,  DNP4s-KLH,  DNP10-MGG, DNP35-HGG, DNP21- 
BSA. In all instances, the radioactivity was 5 ~Ci/106 spleen cells. Specificity activity of DNP4s- 
KLH,  250/zCi/#g; of DNP10-MGG,  190 #Ci//zg; of DNP3.5-HGG,  244 /zCi//zg; of  DNP2I- 
BSA, 135/~Ci//zg; of KLH, 355/zCi//zg; of MGG, 248 #Ci//zg; of HGG, 290/zCi/#g; of BSA, 
366/zCi//zg.  Moles of iodide/moles of carrier: of DNP4s-KLH,  60; of DNP10-MGG,  12; of 
DNPs~-HGG, 14; of DNP21-BSA, 5; of KLH, 100; of MGG, 15; of HGG, 18; of BSA, 12. The 
lower shaded area represents the number of direct anti-DNP PFC  (4- sE) in mice immunized 
with 1 mg of KLH in CFA i.p. 1 hr after X-irradiation with 960 R and repopulated with 50 >( 
106 spleen cells from unprimed BDFI donors 6-wk old. The immune response to DNP was sig- 
nificantly suppressed in all the different experimental groups treated with 12~I-labeled  DNP 
conjugates  (P  <  0.001);  whereas,  in  the groups treated  with the  different nonconjugated 
radioactive carriers, although the response was increased, no significant difference was found 
between each group and the control group. Vertical bar represents one SE. 
B.0K~O0"0 DOV  THEO  GOLAN  AND  YVES  BOREL  311 
responding highly radioactive proteins were used in  the nonconjugated  form. 
This was the case even when KLH-125I was used. However, in view of a recent 
report  by Unanue  (9)  of  the  specific inactivation  of KLH-binding  cells  by 
KLH-12aI, another experiment was done (Table IV), with five times the amount 
of radioactivity and conditions similar to his. In this case, about 50 % reduction 
of anti-DNP PFC was obtained with 25 gCi KLH-eSI/106 spleen cells, whereas 
about  80%  reduction  was  obtained  when  only  5  gCi  DNP-KLH-1251/106 
spleen cells were used. 
Specific Inhibition  by DNP-Protein  Conjugates of the Deletion  of Anti-DNP 
Response.--Since  suppression  of  the  anti-DNP  response  of  spleen  cells  was 
TABLE IV 
Diminution of the Anti-Hapten Response by Treatment with KLH-125I 
In vitro pretreatment of cells 
No. of  Immunization*  PFC/spleen (:t= sE)~: 
mice  Antigen  ~Ci/pg  vCi/10 6 cells  antigen 
6  KLH  --  --  DNP86-KLH  36,260  (3956) 
4  KLH-12aI  330  25  "  16,977  (1494)  § 
* 1 mg of DNPs6-KLH in CFA i.p. 
~c Geometrical mean of direct anti-DNP  PFC (4- sE). 
§ KLH-125I-treated group differed (0.001 <  P  <  0.01) from KLH-treated control group. 
independent  of  the  125I-labeled  protein  carrier  to  which  DNP  was  attached 
during  the in vitro incubation,  we next determined whether  the inhibition  of 
such a deletion  was also carrier independent.  Groups of  mice  (five mice per 
group)  were  repopulated  after  lethal  X-irradiation  with  spleen  cells  treated 
in  vitro  before  their  exposure  to  125I-labeled  DNP  conjugates  (DNP-MGG- 
12~I,  DNP-BSA-125I),  to  unlabeled  DNP-KLH,  KLH  or  Z-DNP-Lys.  The 
immune response to  DNP  was preserved when  DNP-KLH (25  /~g/106  cells) 
was used to inhibit  the inactivation by nonhomologous DNP-protein carrier- 
1251 conjugates  (antigen  concentration 0.02-0.03/zg/106);  however, KLH (un- 
der similar conditions)  had no such  effect,  thus demonstrating  the specificity 
of the inhibition (Table V). This result is a further indication that DNP-bind- 
ing cells recognize and bind the hapten regardless of the carrier to which it is 
bound.  The  unsuccessful  inhibition  by  Z-DNP-Lys,  even  under  a  tenfold 
increased molar concentration,  may be explained by the possibility that  this 
monovalent ligand  binds less efficiently to its specific receptor on the surface 
of  a  lymphoid  cell  and  was  removed from its  specific attachment  when the 
spleen cells  were  washed. 
Duration of Specific Deletion  of Anti-DNP Response.--Incubation  of normal 
mouse  spleen  cells  with  DNP-BSA-12~I  resulted  in  a  suppression  of their  re- 
sponse  to  DNP  after in  vivo stimulation  with  DNP-KLH in  the  irradiated 
host (Fig. 2). The duration of the deletion of anti-DNP response was tested in 
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the  adoptive  transfer,  and  their  anti-DNP  PFC  enumerated  8  days  after 
immunization (namely 1, 2,  and 3 wk after the cell transfer). The results indi- 
cate that both direct and in direct anti-DNP PFC were suppressed for 2 wk; by 
the 3rd wk the immune response was normal (Fig. 3). 
Factors Determining the Inactivation.--In  the course of these experiments, it 
became apparent that  three  technical factors  were  important in inactivating 
TABLE  V 
Specific Inhibition  of the Deletion of A nti-DNP Response 
Group  In vitro pretreatment with  In vitro incubation with 
unlabeled antigen*  DNp-I~SI conjugate:~  PFC/spleen (~ sE)§ 
1  --  --  22,228  (1941) 
2  --  DNP-MGG-125I  6816  (599) 
3  --  DNP-BSA-I2~I  5117  (551) 
4  DNP-KLH  DNP-MGG-125I  18,527  (3002)11 
5  DNP-KLH  DNP-BSA-12sI  37,165  (11,173)[I 
6  KLH  DNP-BSA-125I  1447  (320)  ¶ 
7  F~-DNP-Lys  DNP-BSA-12aI  4921  (535)  ¶ 
* Unprimed spleen cell suspensions were prepared as described in Materials and Methods. 
Before their  exposure to DNp-12~I conjugate, they were incubated  for  1 hr at 0°C  on a 
rotating  table with either  DNP48-KLH  (3  X  10  -n ~/106 cells), KLH (3  X  10  -11 ~/106 
cells), or  N-DNP-Lys  (3  X  10  -1°  M/106 cells), and thereafter  washed twice in minimal 
essential Eagle's medium, their  viability  checked, and their  concentration  readjusted to 50 
X  106/ml. 
:~ leVI-labeled  DNP10-MGG (2 X  10  -13 M/106 cells; 10 JzCi/10  * cells; specific activity 300 
/zCi//zg antigen), l~SI4abeled DNP21-BSA (3 X  10  -13 M/106 cells; 10 ~zCi/106 cells; specific 
activity 400-440/zCi/#g). 
§ Geometric mean (4- sE) of direct anti-DNP PFC in groups of mice (five mice per group) 
repopulated with 50 X  106 spleen ceils after lethal X-irradiation.  All were immunized 1 hr 
after transfer of ceils with 1 mg of DNPs6-KLH in CFA i.p., and 8 days later their immune 
response to DNP was assayed. 
][ Results show no statistical  significant difference between group Nos. 4 and 5 and un- 
treated  controls  (group No.  t); whereas, they were significantly different when compared 
with radioactive-treated controls (P <  0.001) (group Nos. 2 and 3). 
¶ Group Nos. 6 and 7 differed (P  <  0.001) from the untreated controls (group No.  1); 
whereas, they were not significantly different from the radioactive-treated  controls  (group 
No. 3). 
DNP-binding cells:  (a)  the  specific  radioactivity  of  the  conjugate  (which 
relates directly to the degree of iodide substitution); (b)  the concentration of 
antigen per cell; (c)  the total amount of radioactivity per cell, which is directly 
related to the product of the two previous factors. The data in Table VI illus- 
trate  these  observations for  DNP-KLH-125I.  There  was  no  effect  when  low 
specific  radioactivity  and  high  antigen  concentration were  used,  and  only 
partial suppression was achieved when a condition of high specific radioactivity 
and  low  antigen concentration was  present.  In  addition,  despite  a  constant DOV  THEO  GOLAN  AND  YVES  BOP.EL  313 
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FIG. 3.  Duration of specific deletion of anti-DNP response. Black columns represent the 
number of direct PFC  (±  sE)  and  the white columns  the number of indirect PFC  (±SE) 
of  groups  of  mice  (five  mice  per  group)  repopulated  with  spleen  cells  treated  in  vitro 
with  unlabeled  or  125I-labelled  DNP21-BSA  (0.01  #g/106  spleen  cells;  4/zCi/106  spleen 
cells; specific activity  123 /zCi//zg antigen). All animals were immunized  1 hr  after  trans- 
fer with  1 mg of DNPs6-KLH in CFA i.p. The columns on the extreme  left  represent  the 
direct  and  indirect PFC  respectively  of  controls  transplanted  with  cells  treated  in  vitro 
with unlabeled DNP21-BSA  (the  results  were  pooled  since  there  was  no  significant  sta- 
tistical difference in the number of PFC in controls assayed 1, 2, or 3 wk after adoptive trans- 
fer of cells).  The lower shaded area represents the number of anfi-DNP PFC  (± sE) in mice 
immunized with 1 mg of KLH  in CFA i.p.  1 hr after X-irradiation with 960 R  and repopu- 
lated with 50 X  106 normal spleen cells. The results differ significantly (P <  0.001)  from con- 
trols in experimental groups assayed 1 or 2 wk after transfer of cells; whereas there was no sig- 
nificant difference in the experimental group assayed after 3 wk. Vertical bar represent one sE. 
"FABLE VI 
Experimental Conditions for Deletion of DNP-Binding Cells by DNP-KLH-1251 
vCi/ug DNP48-KLH  No. of DNP-KLH  ,uCi/106 cells  PFC/spleen (~ SE)  molecules X 101°/10  e cells 
--  --  --  9343  (1910) 
66  0.56  0.5  9502  (5764) 
80  1.30  1.4  8183  (2799) 
100  3.33  5.0  2254  (859)* 
250  1.84  5.0  857  (259)* 
450  0.83  5.0  3467  (1021)* 
82  4.51  5.0  7181  (2350) 
64  11.60  10.0  22,915  (12,080) 
The  various  experimental conditions are  listed on  the first  three columns.  The  fourth 
column represents the direct anti-DNP PFC/spleen obtained in lethally irradiated  recipient 
animals  (four  to  eight mice per  group)  repopulated with  50  X  106 untreated  or  treated 
spleen cells with DNP-KLHJ25I,  after challenge with 0.2 mg of DNP62-K.LH  in  CFA  i.p. 
* These three groups are significantly different from the controls. In addition,  they  are 
significantly different among themselves as determined by "Studentized Range  Q," a  more 
conservative version of the "Least Significant Difference" (LSD). 
total  radioactivity/cell  ratio,  different  results were  obtained,  depending  upon 
the  degree  of  specific  radioactivity  and  the  concentration  of  conjugate.  This 
indicates  that  specific  conditions  are  required  to  inactivate  the DNP-binding 
cells.  The  results  of  others  (6,  9,  14,  15)  who  studied  the  specific  deletion  of 314  DELETION  OF  HAPTEN-BINDING  CELLS  BY  125I 
different  ABC  by highly  radioactive  antigens  also  demonstrate  that  specific 
requirements for each antigen exist, since the conditions under which ABC were 
inactivated,  were spread over a  wide  range of the  above mentioned  parame- 
ters. Whether the difference in the degree of inactivation by highly radioactive 
hapten-carrier conjugates (Tables III and IV) reflect a difference in the radio- 
sensitivity of various populations of ABC, or whether it is due to a difference in 
the number of cells recognizing a given antigenic determinant, is yet unknown. 
It is also possible that differences in the binding affinities of the highly radio- 
active  conjugates  for  the  receptors  on  the  antigen-binding  cells  account  for 
these results. 
DISCUSSION 
The results show  that in vitro exposure of normal mouse spleen  cells  to  a 
highly" radioactive labeled DNP-protein carrier conjugate, in which  the radio- 
activity was not part of the hapten but solely confined to the  carrier moiety, 
inactivated specifically the cells able to form 19S (direct PFC) and 7S (indirect 
PFC)  antibodies to the same hapten.  Furthermore,  the inactivation of DNP- 
binding cells was highly specific for the hapten and independent of the carrier 
to which the hapten was bound. Although the technique of deleting ABC by in 
vitro  exposure  to  radioactive  antigen  was  originally  called  "antigen-induced 
suicide,"  it  could  just  as likely" constitute  a  "nmrder."  Regardless  of which 
terminology is  chosen,  there  is  no  direct  evidence  that  the  ABC  are  indeed 
killed by this method. The specific suppression of the immune response could 
as well be explained by the  inactivation  of ABC  by an  amount  of radiation 
injury"  that  only" prevents cell  proliferation.  This deletion  was  transient  (2-3 
wk). It may suggest that either new DNP-binding  cells  developed during the 
random maturation of lymphoid stem cells in the inoculum transplanted  into 
the irradiated host, or that the original DNP-binding cells were not killed but 
only  temporarily inactivated,  and  had  recovered from  the  irradiation  injury 
during  the 3 wk interval.  In a  recent publication,  Unanue  (16)  also reported 
that  the  immune response to KLH  (in mice transplanted  with  bone marrow 
cells treated in vitro before transfer with KLH-125I)  was only temporarily sup- 
pressed. 
How can we account for the finding that the immune response to a  hapten 
was prevented by treatment with a hapten-protein-12aI conjugate? Three pos- 
sibilities  can  be  considered:  (a)  carrier-binding  cells  were  inactivated;  (b) 
DNP-binding cells were deleted; and  (c)  a  combination of both  (a and b)  oc- 
curred. The possibility that cells binding antigenic determinants of the carrier 
were inactivated  cannot  be ruled  out,  but  is not likely because:  (a)  In vitro 
treatment of cells with KLH-'25I had no effect on the DNP response, whereas 
treatment  of  cells  under  similar  conditions  with  DNP-KLH-125I  markedly 
suppressed  the  DNP  response  (Fig.  2);  (b)  The  response  to  DNP  was  sup- 
pressed  regardless  of which  radioactive  carrier  conjugate  the  lymphoid  cells DOV  THEO  GOLAN  AND  YVES  BOREL  315 
were exposed to in vitro. We presume that DNP-binding cells were specifically 
inactivated  by  the  radioactivity confined to  the  carrier moiety, which  was 
brought into the immediate environment of the cell by union of DNP with its 
specific receptor on the surface of the hapten-binding cell.  Therefore, to inac- 
tivate a  lymphoid cell recognizing a  given antigenic determinant,  the  radio- 
activity does not need to be part of this determinant. 
It is worth noting that the specificity of the receptor of the hapten-binding 
cell closely mimics the specificity of the anti-DNP antibody, since in both in- 
stances,  they bind DNP independently of the carrier to which it is attached. 
Absence of carrier specificity in hapten-binding cells was further demonstrated 
in  the  experiments in  which  inhibition  of inactivation  was  performed.  Sup- 
pression  of  the  DNP  response was  prevented when  cells were pretreated  in 
vitro with  unlabeled  DNP-KLH before their  exposure to  highly 125I-Iabeled 
nonhomologous DNP  conjugates  (Table  V).  Lack  of  carrier  recognition  by 
hapten-binding  cells was  also  shown  by others when  immunoadsorbent  col- 
umns were used which depleted hapten-binding cells (DNP, NIP), regardless 
of the carrier attached to the immunoadsorbent (17,  18). 
The  immune  response  to  DNP  after  in  vitro  exposure  of  spleen  cells  to 
KLH-125I was  either normal or only partially suppressed  (Fig.  2,  Table IV). 
Diminution of the anti-DNP response occurred only when the total amount of 
radioactivity of KLH-125I was  increased fivefold (as  compared with previous 
experiments using DNP-KLH-I~SI). This observation  raises  several possibili- 
ties:  (a)  Spleen  cells  engaged  in  helper  function  are  less  radiosensitive;  (b) 
Helper cells are exposed to less radiation damage due to fewer receptors on their 
surfaces (19); (c) Helper cells can still fulfill their function in spite of radiation 
injury  that  prevents  only  their  proliferation  and  not  their  antigen-binding 
capacity; (d) The number of helper cells in the spleen is in such an excess, that, 
even after inactivation,  enough cells remain to fulfill this function. Our data 
do not permit choosing from any of these possibilities. However, the3" are in 
agreement with  the  observation of Roelants  and Askonas  (20),  who showed 
that  although  in vitro exposure of hemocyanin-primed spleen cells  to hemo- 
cyanin-125I suppressed  antibody formation to  this  antigen  after  challenge  in 
vivo, this treatment did not interfere with the anti-hapten response to DNP- 
hemocyanin. They attributed this and their other findings to an excess of hemo- 
cyanin-specific helper cell activity in the hemocyanin-primed spleen cells. 
The apparent lack of carrier recognition by hapten-binding cells raises the 
question of the role of carrier recognition in the various immune phenomena. 
For example,  it  is interesting to note that  one of the  carriers used  in  these 
experiments  (as  a  highly  125I-labeled DNP  conjugate)  was  isogeneic  MGG, 
which was shown to be the most effective carrier to induce tolerance of DNP 
(7). Further study of this model should uncover more aspects of the cellular 
basis  of antigen  recognition and  its importance in  the  development of both 
tolerance and immunity. 316  DELETION OF  HAl)TEN-BINDING CELLS ]3Y  125I 
SUMMARY 
Exposure of normal mouse spleen cells in vitro to highly 125I-labeled dinitro- 
phenyl  (DNP)-protein  carrier conjugates specifically inactivated cells able to 
mount  an  immune  response to that hapten  after in vivo challenge. The  dele- 
tion was hapten specific and independent of the radioactive carrier to which the 
hapten  was  bound.  DNP-binding  cells were  inactivated by radioactivity that 
was not part of the hapten, but was solely confined to the carrier moiety. The 
deletion  of  the  anti-DNP  response  lasted  2-3  wk  and  could  be  specifically 
inhibited. 
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